Spike S1 Neutralizing Antibody (B.1.617.2, B.1.617.2.1, B.1.1.7, B.1.351, B.1.429, and P.1 Variants) (Clone C-A11) (SARS-CoV-2)

Product Code
AMS.101024
$0.00
Order Support
Shipping Information
Product Updates
  • Keep up to date with product offers, resources and news

  • Sign up

This purified rabbit monoclonal antibody recognizes recombinant wildtype SARS-CoV-2 Spike RBD and trimeric spike proteins. Additionally, this antibody cross-reacts with the B.1.1.7 variant, originally discovered in the U.K, and the B.1.351 variant, originally discovered in South Africa, for both the Spike RBD and trimeric proteins. This neutralizing antibody impedes the interaction between SARS-CoV-2 spike proteins and ACE2 receptor. ACE2 receptor is known to mediate COVID-19 infection through direct binding of the SARS-CoV2 Spike protein. This neutralizing antibody has been functionally tested using AMSBIO Spike RBD: ACE2 Inhibitor Screening Kits ( AMSBIO , #78018, #78133, #78152). This antibody not been tested for cross reactivity with other SARS-CoV-2 variants.
More Information
SKU AMS.101024
Size 100 µg
Species Rabbit
isotype Rabbit Monoclonal IgG
Application The rabbit monoclonal neutralizing IgG can be used for functional assays testing inhibitors against SARS-CoV-2 Spike protein and ACE2 binding.
Accession No MN908947
Gene id MN908947
Gene synonyms covid, covid-19, covid19, coronavirus, B1135 antibody, B117 antibody, SARS neutralizing antibody, Spike S1 neutralizing antibody, UK variant antibody, SARS CoV 2 neutralizing antibody, South African variant Antibody
Format Aqueous buffer solution
Storage Supplied at 0.5 mg/ml
Shipping Temp +4°C (gel packs)
Supplier Name BPS Bioscience Inc
For more details visit our SARS-CoV-2 Spike Mutants page >